5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role of Reduced Sarco-Endoplasmic Reticulum Ca 2+-ATPase Function on Sarcoplasmic Reticulum Ca 2+ Alternans in the Intact Rabbit Heart

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sarcoplasmic reticulum (SR) Ca 2+ cycling is tightly regulated by ryanodine receptor (RyR) Ca 2+ release and sarco-endoplasmic reticulum Ca 2+-ATPase (SERCA) Ca 2+ uptake during each excitation–contraction coupling cycle. We previously showed that RyR refractoriness plays a key role in the onset of SR Ca 2+ alternans in the intact rabbit heart, which contributes to arrhythmogenic action potential duration (APD) alternans. Recent studies have also implicated impaired SERCA function, a key feature of heart failure, in cardiac alternans and arrhythmias. However, the relationship between reduced SERCA function and SR Ca 2+ alternans is not well understood. Simultaneous optical mapping of transmembrane potential (V m) and SR Ca 2+ was performed in isolated rabbit hearts ( n = 10) using the voltage-sensitive dye RH237 and the low-affinity Ca 2+ indicator Fluo-5N-AM. Alternans was induced by rapid ventricular pacing. SERCA was inhibited with cyclopiazonic acid (CPA; 1–10 μM). SERCA inhibition (1, 5, and 10 μM of CPA) resulted in dose-dependent slowing of SR Ca 2+ reuptake, with the time constant ( tau) increasing from 70.8 ± 3.5 ms at baseline to 85.5 ± 6.6, 129.9 ± 20.7, and 271.3 ± 37.6 ms, respectively ( p < 0.05 vs. baseline for all doses). At fast pacing frequencies, CPA significantly increased the magnitude of SR Ca 2+ and APD alternans, most strongly at 10 μM (pacing cycle length = 220 ms: SR Ca 2+ alternans magnitude: 57.1 ± 4.7 vs. 13.4 ± 8.9 AU; APD alternans magnitude 3.8 ± 1.9 vs. 0.2 ± 0.19 AU; p < 0.05 10 μM of CPA vs. baseline for both). SERCA inhibition also promoted the emergence of spatially discordant alternans. Notably, at all CPA doses, alternation of SR Ca 2+ release occurred prior to alternation of diastolic SR Ca 2+ load as pacing frequency increased. Simultaneous optical mapping of SR Ca 2+ and V m in the intact rabbit heart revealed that SERCA inhibition exacerbates pacing-induced SR Ca 2+ and APD alternans magnitude, particularly at fast pacing frequencies. Importantly, SR Ca 2+ release alternans always occurred before the onset of SR Ca 2+ load alternans. These findings suggest that even in settings of diminished SERCA function, relative refractoriness of RyR Ca 2+ release governs the onset of intracellular Ca 2+ alternans.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          Cardiac excitation-contraction coupling.

          Of the ions involved in the intricate workings of the heart, calcium is considered perhaps the most important. It is crucial to the very process that enables the chambers of the heart to contract and relax, a process called excitation-contraction coupling. It is important to understand in quantitative detail exactly how calcium is moved around the various organelles of the myocyte in order to bring about excitation-contraction coupling if we are to understand the basic physiology of heart function. Furthermore, spatial microdomains within the cell are important in localizing the molecular players that orchestrate cardiac function.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

            Adeno-associated virus type 1/sarcoplasmic reticulum Ca(2+)-ATPase was assessed in a randomized, double-blind, placebo-controlled, phase 2 study in patients with advanced heart failure. Thirty-nine patients received intracoronary adeno-associated virus type 1/sarcoplasmic reticulum Ca(2+)-ATPase or placebo. Seven efficacy parameters were assessed in 4 domains: symptoms (New York Heart Association class, Minnesota Living With Heart Failure Questionnaire), functional status (6-minute walk test, peak maximum oxygen consumption), biomarker (N-terminal prohormone brain natriuretic peptide), and left ventricular function/remodeling (left ventricular ejection fraction, left ventricular end-systolic volume), plus clinical outcomes. The primary end point success criteria were prospectively defined as achieving efficacy at 6 months in the group-level (concordant improvement in 7 efficacy parameters and no clinically significant worsening in any parameter), individual-level (total score for predefined clinically meaningful changes in 7 efficacy parameters), or outcome end points (cardiovascular hospitalizations and time to terminal events). Efficacy in 1 analysis had to be associated with at least a positive trend in the other 2 analyses. This combination of requirements resulted in a probability of success by chance alone of 2.7%. The high-dose group versus placebo met the prespecified criteria for success at the group-level, individual-level, and outcome analyses (cardiovascular hospitalizations) at 6 months (confirmed at 12 months) and demonstrated improvement or stabilization in New York Heart Association class, Minnesota Living With Heart Failure Questionnaire, 6-minute walk test, peak maximum oxygen consumption, N-terminal prohormone brain natriuretic peptide levels, and left ventricular end-systolic volume. Significant increases in time to clinical events and decreased frequency of cardiovascular events were observed at 12 months (hazard ratio=0.12; P=0.003), and mean duration of cardiovascular hospitalizations over 12 months was substantially decreased (0.4 versus 4.5 days; P=0.05) on high-dose treatment versus placebo. There were no untoward safety findings. The Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) study demonstrated safety and suggested benefit of adeno-associated virus type 1/sarcoplasmic reticulum Ca(2+)-ATPase in advanced heart failure, supporting larger confirmatory trials. http://www.clinicaltrials.gov. Unique identifier: NCT00454818.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanism linking T-wave alternans to the genesis of cardiac fibrillation.

              Although T-wave alternans has been closely associated with vulnerability to ventricular arrhythmias, the cellular processes underlying T-wave alternans and their role, if any, in the mechanism of reentry remain unclear. -T-wave alternans on the surface ECG was elicited in 8 Langendorff-perfused guinea pig hearts during fixed-rate pacing while action potentials were recorded simultaneously from 128 epicardial sites with voltage-sensitive dyes. Alternans of the repolarization phase of the action potential was observed above a critical threshold heart rate (HR) (209+/-46 bpm) that was significantly lower (by 57+/-36 bpm) than the HR threshold for alternation of action potential depolarization. The magnitude (range, 2.7 to 47.0 mV) and HR threshold (range, 171 to 272 bpm) of repolarization alternans varied substantially between cells across the epicardial surface. T-wave alternans on the surface ECG was explained primarily by beat-to-beat alternation in the time course of cellular repolarization. Above a critical HR, membrane repolarization alternated with the opposite phase between neighboring cells (ie, discordant alternans), creating large spatial gradients of repolarization. In the presence of discordant alternans, a small acceleration of pacing cycle length produced a characteristic sequence of events: (1) unidirectional block of an impulse propagating against steep gradients of repolarization, (2) reentrant propagation, and (3) the initiation of ventricular fibrillation. Repolarization alternans at the level of the single cell accounts for T-wave alternans on the surface ECG. Discordant alternans produces spatial gradients of repolarization of sufficient magnitude to cause unidirectional block and reentrant ventricular fibrillation. These data establish a mechanism linking T-wave alternans of the ECG to the pathogenesis of sudden cardiac death.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Physiol
                Front Physiol
                Front. Physiol.
                Frontiers in Physiology
                Frontiers Media S.A.
                1664-042X
                11 May 2021
                2021
                : 12
                : 656516
                Affiliations
                [1] 1Department of Pharmacology, School of Medicine, University of California , Davis, Davis, CA, United States
                [2] 2Institute of Cardiovascular and Medical Sciences, University of Glasgow , Glasgow, United Kingdom
                Author notes

                Edited by: Daniel M. Johnson, The Open University, United Kingdom

                Reviewed by: Christopher O’Shea, University of Birmingham, United Kingdom; Kenneth Laurita, Case Western Reserve University, United States; Antonio Zaza, University of Milano-Bicocca, Italy

                *Correspondence: Crystal M. Ripplinger, cripplinger@ 123456ucdavis.edu

                This article was submitted to Cardiac Electrophysiology, a section of the journal Frontiers in Physiology

                Article
                10.3389/fphys.2021.656516
                8144333
                34045974
                d47335f3-147d-4b34-907e-12abebd675de
                Copyright © 2021 Wang, Myles, Lee, Bers and Ripplinger.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 20 January 2021
                : 29 March 2021
                Page count
                Figures: 5, Tables: 0, Equations: 0, References: 54, Pages: 11, Words: 0
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: P01 HL141084
                Award ID: R01 HL111600
                Funded by: Wellcome Trust 10.13039/100010269
                Award ID: 105907/Z/14/Z
                Categories
                Physiology
                Original Research

                Anatomy & Physiology
                sarco-endoplasmic reticulum ca2+-atpase,sarcoplasmic reticulum ca2+,optical mapping,alternans,arrhythmia

                Comments

                Comment on this article